Keywords: anylam, extends, govt, funding, rnais, biological, threats

Anylam extends US govt funding of RNAis for biological threats

Article | 18 August 2008

Alnylam Pharmaceuticals, a leading US RNAi therapeutics company, says that the National Institute of Allergy and Infectious Diseases, a component ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Alnylam Pharmaceuticals

Go to company listing